You have free access to this content

Hepatology

Cover image for Vol. 53 Issue 5

May 2011

Volume 53, Issue 5

Pages 1417–1788

  1. Mater's Perspective

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Telomerase mutation: A genetic risk factor for cirrhosis (pages 1430–1432)

      Roongruedee Chaiteerakij and Lewis R. Roberts

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24304

    3. You have free access to this content
      Is it the end of the line for the EMT? (pages 1433–1435)

      Tatiana Kisseleva and David A. Brenner

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24312

  3. Viral Hepatitis

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics (pages 1436–1445)

      Laura Mensa, Gonzalo Crespo, Matthew J. Gastinger, Juraj Kabat, Sofía Pérez-del-Pulgar, Rosa Miquel, Suzanne U. Emerson, Robert H. Purcell and Xavier Forns

      Version of Record online: 3 FEB 2011 | DOI: 10.1002/hep.24110

    2. You have full text access to this OnlineOpen article
      Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance (pages 1446–1454)

      Julia di Iulio, Angela Ciuffi, Karen Fitzmaurice, Dermot Kelleher, Margalida Rotger, Jacques Fellay, Raquel Martinez, Sara Pulit, Hansjakob Furrer, Huldrych F. Günthard, Manuel Battegay, Enos Bernasconi, Patrick Schmid, Bernard Hirschel, Eleanor Barnes, Paul Klenerman, Amalio Telenti, Andri Rauch and and the Swiss HIV Cohort Study

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24263

    3. You have free access to this content
      Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice (pages 1455–1467)

      Jiabin Yan, Zuliang Jie, Lifei Hou, Joao L. Wanderley, Lynn Soong, Shalini Gupta, Suimin Qiu, Tehsheng Chan and Jiaren Sun

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24270

    4. You have free access to this content
      Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children (pages 1468–1475)

      James R. Rodrigue, William Balistreri, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith, Steven J. Lobritto, Kathleen B. Schwarz, Patricia R. Robuck, Bruce Barton and Regino P. González-Peralta

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24248

    5. You have free access to this content
      Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1 (pages 1476–1485)

      Xiaoyong Zhang, Ejuan Zhang, Zhiyong Ma, Rongjuan Pei, Min Jiang, Joerg F. Schlaak, Michael Roggendorf and Mengji Lu

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24195

    6. You have free access to this content
      Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir (pages 1486–1493)

      Jung Min Lee, Sang Hoon Ahn, Hyon Suk Kim, Hana Park, Hye Young Chang, Do Young Kim, Seong Gyu Hwang, Kyu Sung Rim, Chae Yoon Chon, Kwang-Hyub Han and Jun Yong Park

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24221

    7. You have free access to this content
      Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection (pages 1494–1503)

      Anna Schurich, Pooja Khanna, A. Ross Lopes, Ki Jun Han, Dimitra Peppa, Lorenzo Micco, Gaia Nebbia, Patrick T.F. Kennedy, Anna-Maria Geretti, Geoffrey Dusheiko and Mala K. Maini

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24249

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects (pages 1504–1514)

      Sven Haufe, Stefan Engeli, Petra Kast, Jana Böhnke, Wolfgang Utz, Verena Haas, Mario Hermsdorf, Anja Mähler, Susanne Wiesner, Andreas L. Birkenfeld, Henrike Sell, Christoph Otto, Heidrun Mehling, Friedrich C. Luft, Juergen Eckel, Jeanette Schulz-Menger, Michael Boschmann and Jens Jordan

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24242

    2. You have free access to this content
      Hepatic autophagy mediates endoplasmic reticulum stress–induced degradation of misfolded apolipoprotein B (pages 1515–1525)

      Wei Qiu, Jing Zhang, Mark J. Dekker, Huajin Wang, Ju Huang, John H. Brumell and Khosrow Adeli

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24269

    3. You have free access to this content
      Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice (pages 1526–1537)

      Bharath Nath, Ivan Levin, Timea Csak, Jan Petrasek, Christian Mueller, Karen Kodys, Donna Catalano, Pranoti Mandrekar and Gyongyi Szabo

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24256

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma (pages 1538–1548)

      Byoung Kwon Yoo, Prasanna K. Santhekadur, Rachel Gredler, Dong Chen, Luni Emdad, Sujit Bhutia, Lewis Pannell, Paul B. Fisher and Devanand Sarkar

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24216

    2. You have free access to this content
      Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma (pages 1549–1557)

      Luca Di Tommaso, Annarita Destro, Valentina Fabbris, Gaia Spagnuolo, Anna Laura Fracanzani, Silvia Fargion, Marco Maggioni, Carlo Patriarca, Roberto Maria Macchi, Michela Quagliuolo, Mauro Borzio, Massimo Iavarone, Angelo Sangiovanni, Massimo Colombo and Massimo Roncalli

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24218

    3. You have free access to this content
    4. You have free access to this content
      Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation (pages 1570–1579)

      Prashant Bhangui, Eric Vibert, Pietro Majno, Chady Salloum, Paola Andreani, Joao Zocrato, Philippe Ichai, Faouzi Saliba, Rene Adam, Denis Castaing and Daniel Azoulay

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24231

    5. You have free access to this content
      Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas (pages 1580–1589)

      Rita Golfieri, Alberta Cappelli, Alessandro Cucchetti, Fabio Piscaglia, Maria Carpenzano, Eugenia Peri, Matteo Ravaioli, Antonia D'Errico-Grigioni, Antonio Daniele Pinna and Luigi Bolondi

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24246

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis (pages 1590–1599)

      Natalie A. Molodecky, Hashim Kareemi, Rohan Parab, Herman W. Barkema, Hude Quan, Robert P. Myers and Gilaad G. Kaplan

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24247

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Constitutional telomerase mutations are genetic risk factors for cirrhosis (pages 1600–1607)

      Rodrigo T. Calado, Jennifer Brudno, Paulomi Mehta, Joseph J. Kovacs, Colin Wu, Marco A. Zago, Stephen J. Chanock, Thomas D. Boyer and Neal S. Young

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24173

    2. You have free access to this content
      Telomerase gene mutations are associated with cirrhosis formation (pages 1608–1617)

      Daniel Hartmann, Ujala Srivastava, Michaela Thaler, Karin N. Kleinhans, Gisèle N'Kontchou, Annika Scheffold, Kerstin Bauer, Ramona F. Kratzer, Natalia Kloos, Sarah-Fee Katz, Zhangfa Song, Yvonne Begus-Nahrmann, Alexander Kleger, Guido von Figura, Pavel Strnad, André Lechel, Cagatay Günes, Andrej Potthoff, Katja Deterding, Heiner Wedemeyer, Zhenyu Ju, Ge Song, Feng Xiao, Sonja Gillen, Hubert Schrezenmeier, Thomas Mertens, Marianne Ziol, Helmut Friess, Michael Jarek, Michael P. Manns, Michel Beaugrand and K. Lenhard Rudolph

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24217

    3. You have free access to this content
      Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice (pages 1618–1628)

      William D. Stuart, Rishikesh M. Kulkarni, Jerilyn K. Gray, Juozas Vasiliauskas, Mike A. Leonis and Susan E. Waltz

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24239

    4. You have free access to this content
      Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice (pages 1629–1640)

      Christophe Van Steenkiste, Jordi Ribera, Anja Geerts, Montse Pauta, Sònia Tugues, Christophe Casteleyn, Louis Libbrecht, Kim Olievier, Ben Schroyen, Hendrik Reynaert, Leo A. van Grunsven, Bram Blomme, Stephanie Coulon, Femke Heindryckx, Martine De Vos, Jean Marie Stassen, Stefan Vinckier, Jose Altamirano, Ramón Bataller, Peter Carmeliet, Hans Van Vlierberghe, Isabelle Colle and Manuel Morales-Ruiz

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24238

  8. Liver Injury/Regeneration

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice (pages 1641–1650)

      Arun Thenappan, Vivek Shukla, Feras J. Abdul Khalek, Ying Li, Kirti Shetty, Pu Liu, Lu Li, Randy L. Johnson, Lynt Johnson and Lopa Mishra

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24111

    2. You have free access to this content
      MicroRNA-221 regulates FAS-induced fulminant liver failure (pages 1651–1661)

      Amar Deep Sharma, Nidhi Narain, Eva-Maria Händel, Marcus Iken, Nishant Singhal, Toni Cathomen, Michael P. Manns, Hans R. Schöler, Michael Ott and Tobias Cantz

      Version of Record online: 11 MAR 2011 | DOI: 10.1002/hep.24243

    3. You have free access to this content
      Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury (pages 1662–1675)

      Sang Won Park, Mihwa Kim, Kevin M. Brown, Vivette D. D'Agati and H. Thomas Lee

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24253

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer (pages 1676–1684)

      Hye Jung Baek, Michael J. Pishvaian, Yi Tang, Tae Hyun Kim, Shaoxian Yang, Majed El Zouhairi, Jon Mendelson, Kirti Shetty, Bhaskar Kallakury, Deborah L. Berry, Kyung Hwan Shin, Bibhuti Mishra, E. Premkumar Reddy, Sang Soo Kim and Lopa Mishra

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24128

    2. You have free access to this content
      Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis (pages 1685–1695)

      Andrew S. Chu, Rosalyn Diaz, Jia-Ji Hui, Kilangsungla Yanger, Yiwei Zong, Gianfranco Alpini, Ben Z. Stanger and Rebecca G. Wells

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24206

    3. You have full text access to this OnlineOpen article
      Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk (pages 1696–1707)

      Janka Mátrai, Alessio Cantore, Cynthia C. Bartholomae, Andrea Annoni, Wei Wang, Abel Acosta-Sanchez, Ermira Samara-Kuko, Liesbeth De Waele, Ling Ma, Pietro Genovese, Martina Damo, Anne Arens, Kevin Goudy, Timothy C. Nichols, Christof von Kalle, Marinee K. L. Chuah, Maria Grazia Roncarolo, Manfred Schmidt, Thierry VandenDriessche and Luigi Naldini

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24230

    4. You have free access to this content
      Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes (pages 1708–1718)

      Yue-Lei Chen, Jing Lv, Xiao-Lei Ye, Ming-Yu Sun, Qin Xu, Cheng-Hai Liu, Li-Hua Min, Hui-Ping Li, Ping Liu and Xiaoyan Ding

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24254

    5. You have free access to this content
      Hepatic differentiation of amniotic epithelial cells (pages 1719–1729)

      Fabio Marongiu, Roberto Gramignoli, Kenneth Dorko, Toshio Miki, Aarati R. Ranade, Maria Paola Serra, Silvia Doratiotto, Marcella Sini, Shringi Sharma, Keitaro Mitamura, Tiffany L. Sellaro, Veysel Tahan, Kristen J. Skvorak, Ewa C. S. Ellis, Stephen F. Badylak, Julio C. Davila, Ronald Hines, Ezio Laconi and Stephen C. Strom

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24255

    6. You have free access to this content
      The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice (pages 1730–1741)

      Yong-Han Paik, Keiko Iwaisako, Ekihiro Seki, Sayaka Inokuchi, Bernd Schnabl, Christoph H. Österreicher, Tatiana Kisseleva and David A. Brenner

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24281

  10. Reviews

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
    2. You have free access to this content
      The contribution of endoplasmic reticulum stress to liver diseases (pages 1752–1763)

      Lily Dara, Cheng Ji and Neil Kaplowitz

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24279

  11. Hepatology Elsewhere

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      The hepcidin circuits act: Balancing iron and inflammation (pages 1764–1766)

      Bryan D. Maliken, James E. Nelson and Kris V. Kowdley

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24267

    2. You have free access to this content
      Neurofibromatosis type 2/merlin: Sharpening the Myth of Prometheus (pages 1767–1770)

      Oliver Drvarov and Francisco Javier Cubero

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24282

  12. Image of the Month

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Massive hepatic echinococcosis (pages 1771–1772)

      Seth Sweetser and Conor G. Loftus

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24139

  13. Correspondence

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Need for a three-focused approach to nonalcoholic fatty liver disease (page 1773)

      Giovanni Musso, Roberto Gambino and Maurizio Cassader

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24070

    2. You have free access to this content
      Reply (page 1774)

      Nazim A. Ghouri, David Preiss and Naveed Sattar

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24138

    3. You have free access to this content
    4. You have free access to this content
      Reply (pages 1775–1776)

      William Sievert, Gregory J. Dore, Stuart K. Roberts and On behalf of the CHARIOT Study Group

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24250

    5. You have free access to this content
      Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma (page 1776)

      Stefano Ginanni Corradini, Maria Antonella Burza, Antonio Molinaro and Stefano Romeo

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24244

    6. You have free access to this content
    7. You have free access to this content
      The impact of human immunodeficiency virus infection in liver transplantation for hepatocellular carcinoma (pages 1777–1778)

      Fabrizio Di Benedetto, Giuseppe Tarantino, Roberto Montalti, Giuseppe D'Amico, Stefania Cocchi and Giorgio E. Gerunda

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24235

    8. You have free access to this content
      Reply (pages 1778–1779)

      Jean-Charles Duclos-Vallée, René Adam, Eric Vibert and Didier Samuel

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24264

    9. You have free access to this content
      Noninvasive assessment of cystic fibrosis–associated liver disease with acoustic radiation force impulse imaging (pages 1779–1780)

      Melania Manco, Cristina Lo Zupone, Alessandro Latini, Vincenzina Lucidi and Lidia Monti

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24245

    10. You have free access to this content
    11. You have free access to this content
      Methods and interest of noninvasive assessment of liver fibrosis are still in debate (page 1781)

      Françoise Degos, Louis Lebrun, Paul Perez and Isabelle Durand-Zaleski

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24276

    12. You have free access to this content
      Noninvasive assessment of liver fibrosis: The need for better validation (pages 1781–1782)

      Emmanuel A. Tsochatzis, Giacomo Germani, Andrew Hall, Pinelopi M anousou, Amar P. Dhillon and Andrew K. Burroughs

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24271

    13. You have free access to this content
      Reply (pages 1782–1783)

      Stella M. Martínez, Gonzalo Crespo, Miquel Navasa and Xavier Forns

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24300

    14. You have free access to this content
      Beta-blockers in patients with cirrhosis and refractory ascites (page 1783)

      Albillos Agustín and Zamora Javier

      Version of Record online: 28 DEC 2010 | DOI: 10.1002/hep.24032

    15. You have free access to this content
    16. You have free access to this content
    17. You have free access to this content
    18. You have free access to this content
      Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases (pages 1785–1786)

      Federico Salamone, Fabio Galvano and Giovanni Li Volti

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24115

    19. You have free access to this content
      Does the donor mannose-binding lectin genotype really predict the risk of bacterial infections after liver transplantation? (pages 1786–1787)

      Lilian A. Curvelo, Emmeloes de Mare-Bredemeijer, Ilse de Canck, Martine van Thielen, Geert Kazemier, Herold Metselaar and Jaap Kwekkeboom

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24114

  14. Corrections

    1. Top of page
    2. Mater's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Correction (page 1788)

      Version of Record online: 22 APR 2011 | DOI: 10.1002/hep.24302

      This article corrects:

SEARCH

SEARCH BY CITATION